NASDAQ$CCRN

Cross Country Healthcare Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Announced third quarter 2024 financial results, reflecting revenue, Adjusted EBITDA, and Adjusted EPS within guidance ranges.

Cross Country Healthcare's third quarter results showed stabilization across the core business with momentum in Homecare, Physician, and Education Staffing. Revenue was $315.1 million, a decrease of 29% year-over-year, and net income attributable to common stockholders was $2.6 million.

  • Revenue, Adjusted EBITDA, and Adjusted EPS all within guidance ranges
  • Physician Staffing and Homecare Staffing experienced sequential and year-over-year revenue growth
  • Secured a three-year contract renewal with our largest managed service program
  • Continued strong balance sheet with $64 million of cash on hand and no debt as of September 30, 2024

Headline financials

Total Revenue

$315M

Previous: $442M-28.8%
EPS

$0.08

Previous: $0.39-79.5%
Capital Expenditures

-$6.18M

Previous: -$11.1M+44.3%
Free Cash Flow

-$3.63M

Previous: $1.71M-311.8%
Net Income

$2.56M

Previous: $12.8M-80.1%
Operating Income

$2.85M

Previous: $20.3M-85.9%
Gross Profit

-$251M

Previous: -$345M+27.2%
Cash & Equivalents

$64M

Previous: $14.3M+347.7%
Total Assets

$597M

Previous: $708M-15.6%
Stock-Based Comp

$870K

Previous: $1.43M-39.3%

Revenue & EPS history

Cross Country Healthcare · Revenue · Quarterly

$315M

Q3 2024-28.8%vs Q3 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Cross Country Healthcare · $442M total across 2 segments · Q3 2023

  • Nurse and Allied Staffing
    $397M-35.2%
  • Physician Staffing
    $45.7M+91.8%

Forward guidance

The guidance below applies to management’s expectations for the fourth quarter of 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-2.7%

Avg return

Earnings day

-1.5%

Avg return

5 days after

+0.5%

Avg return

30 days after

44%

28 / 64 earnings

Positive

+24.6%

Q3 2021

Best reaction

-33.6%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+0.4%+0.8%
Q4 2025+8.2%+7.9%+0.5%
Q3 2025-14.1%-7.2%-32.9%
Q1 2025+0.4%+0.8%-6.7%
Q4 2024+0.3%-6.0%-13.9%
Q3 2024+7.2%-6.1%+57.9%
Q2 2024-2.7%-8.2%-17.3%
Q1 2024-4.9%-9.0%-14.1%
Q4 2023-2.7%-0.3%+5.7%
Q3 2023-14.0%-19.0%-10.7%
Q2 2023-14.7%-14.0%-3.8%
Q1 2023+5.1%+9.9%+26.1%
Q4 2022-5.6%+3.2%-13.2%
Q3 2022-2.5%-11.3%-2.8%
Q2 2022-13.7%-14.1%-7.6%
Q1 2022-2.6%-7.1%+0.9%
Q4 2021-1.5%+6.6%+2.4%
Q3 2021+24.6%+18.0%+21.1%
Q2 2021+23.0%+14.6%+29.7%
Q1 2021+16.5%+24.0%+17.4%
Q4 2020+18.9%+24.6%+33.8%
Q3 2020-5.0%-3.0%+9.3%
Q2 2020+9.6%+4.7%+1.6%
Q1 2020-4.8%-2.0%+7.6%
Q4 2019+0.4%-12.2%-27.7%
Q3 2019+14.2%+16.9%+10.9%
Q2 2019-0.8%-5.5%+5.6%
Q1 2019+4.7%+18.7%+0.9%
Q4 2018-3.6%-11.6%-22.5%
Q3 2018+7.8%+3.4%+2.7%
Q2 2018-30.9%-26.0%-14.7%
Q1 2018-16.7%-11.0%-4.3%
Q4 2017-18.8%-13.6%-15.8%
Q3 2017-9.6%-13.8%-2.6%
Q2 2017+3.1%+1.2%+2.5%
Q1 2017-13.0%-15.1%-16.7%
Q4 2016+3.4%-5.3%-7.2%
Q3 2016+22.9%+24.3%+31.7%
Q2 2016-11.5%-17.0%-14.2%
Q1 2016+10.0%
Q4 2015-21.9%
Q3 2015+9.5%
Q2 2015+10.1%
Q1 2015-4.6%
Q4 2014-9.6%
Q3 2014-0.5%
Q2 2014+1.8%
Q1 2014-14.3%
Q4 2013-22.3%
Q3 2013+3.1%
Q2 2013-3.3%
Q1 2013+0.4%
Q4 2009-5.5%
Q3 2012-0.9%
Q2 2012-5.5%
Q1 2011-3.1%
Q1 2012+11.8%
Q4 2011+0.8%
Q3 2010+2.5%
Q3 2011+2.5%
Q2 2011-33.6%
Q4 2010-33.6%
Q2 2010-33.6%
Q1 2010-7.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro